Bristol-Myers Squibb Company (BMY)

NYSE: BMY · Real-Time Price · USD

Compare

61.99

+2.47 (4.15%)

At close: Feb 6, 2026, 4:00 PM EST

61.75

-0.24 (-0.39%)

After-hours: Feb 6, 2026, 7:59 PM EST

BMY Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	48,194	48,300	45,006	46,159	46,385
Revenue Growth (YoY)	-0.22%	7.32%	-2.50%	-0.49%	9.10%
Cost of Revenue	13,194	11,949	10,518	10,137	9,940
Gross Profit	35,000	36,351	34,488	36,022	36,445
Selling, General & Admin	7,149	7,865	7,678	7,777	7,655
Research & Development	9,492	9,782	9,112	9,509	10,195
Amortization of Goodwill & Intangibles	3,317	8,872	9,047	9,595	10,023
Operating Expenses	19,958	26,519	25,837	26,881	27,873
Operating Income	15,042	9,832	8,651	9,141	8,572
Interest Expense	-1,891	-1,958	-1,161	-1,205	-1,303
Interest & Investment Income	586	478	449	171	39
Earnings From Equity Investments	-	44	-38	-108	231
Currency Exchange Gain (Loss)	-	31	160	148	32
Other Non Operating Income (Expenses)	1,855	1,481	2,119	1,827	1,708
EBT Excluding Unusual Items	15,592	9,908	10,180	9,974	9,279
Merger & Restructuring Charges	-1,089	-1,968	-893	-520	-724
Gain (Loss) on Sale of Investments	280	-28	-122	-693	514
Gain (Loss) on Sale of Assets	-	-15	-	211	9
Asset Writedown	-949	-2,819	-107	-	-
Legal Settlements	-434	-84	-10	-178	-82
Other Unusual Items	-351	-	305	-266	261
Pretax Income	9,328	-8,379	8,440	7,713	8,098
Income Tax Expense	2,272	554	400	1,368	1,084
Earnings From Continuing Operations	7,056	-8,933	8,040	6,345	7,014
Minority Interest in Earnings	-2	-15	-15	-18	-20
Net Income	7,054	-8,948	8,025	6,327	6,994
Net Income to Common	7,054	-8,948	8,025	6,327	6,994
Net Income Growth	-	-	26.84%	-9.54%	-
Shares Outstanding (Basic)	2,034	2,027	2,069	2,130	2,221
Shares Outstanding (Diluted)	2,039	2,027	2,078	2,146	2,245
Shares Change (YoY)	0.59%	-2.45%	-3.17%	-4.41%	-0.58%
EPS (Basic)	3.47	-4.41	3.88	2.97	3.15
EPS (Diluted)	3.46	-4.41	3.86	2.95	3.12
EPS Growth	-	-	30.85%	-5.45%	-
Free Cash Flow	-	13,942	12,651	11,948	15,234
Free Cash Flow Per Share	-	6.88	6.09	5.57	6.79
Dividend Per Share	2.490	2.420	2.310	2.190	2.010
Dividend Growth	2.89%	4.76%	5.48%	8.96%	9.24%
Gross Margin	72.62%	75.26%	76.63%	78.04%	78.57%
Operating Margin	31.21%	20.36%	19.22%	19.80%	18.48%
Profit Margin	14.64%	-18.53%	17.83%	13.71%	15.08%
Free Cash Flow Margin	-	28.87%	28.11%	25.88%	32.84%
EBITDA	19,113	19,407	18,420	19,423	19,329
EBITDA Margin	39.66%	40.18%	40.93%	42.08%	41.67%
D&A For EBITDA	4,071	9,575	9,769	10,282	10,757
EBIT	15,042	9,832	8,651	9,141	8,572
EBIT Margin	31.21%	20.36%	19.22%	19.80%	18.48%
Effective Tax Rate	24.36%	-	4.74%	17.74%	13.39%
Revenue as Reported	48,194	48,300	45,006	46,159	46,385
Advertising Expenses	-	1,500	1,400	1,300	1,300

Updated Feb 5, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q